• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病治疗方式的选择:决策中哪些因素至关重要?

ESRD treatment modality selection: which factors are important in the decision?

作者信息

Groome P A, Hutchinson T A, Prichard S S

机构信息

McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada.

出版信息

Adv Perit Dial. 1991;7:54-6.

PMID:1680457
Abstract

UNLABELLED

The purpose of this study was to determine which factors are most important in choosing between ESRD treatments and to assess if patients, R.N.'s and M.D.'s agree or differ as to the level of importance of different factors.

METHODS

22 patients, 11 R.N.'s and 10 M.D.'s were interviewed to determine which factors should be considered. Forty-three factors were identified relevant to CAPD and hemodialysis. Then 14 patients, 8 R.N.'s and M.D.'s were asked to rate each of these factors on a scale of 1-10 (10 being most important) and the average score for each was computed. The factors were then ranked in order of importance (1 being most important). The results revealed that peritonitis ranked as overall the most important factor in determining treatment modality choice. In general, life style considerations ranked higher than medical consequences of a specific therapy. There was concordance amongst the three groups in some areas but there were also differences between patients, R.N.'s and M.D.'s. This raises important issues with regards to the adequacy of patient counselling.

摘要

未标注

本研究的目的是确定在选择终末期肾病治疗方法时哪些因素最为重要,并评估患者、注册护士和医生在不同因素的重要性程度上是否意见一致或存在差异。

方法

对22名患者、11名注册护士和10名医生进行了访谈,以确定应考虑哪些因素。确定了43个与持续性非卧床腹膜透析和血液透析相关的因素。然后让14名患者、8名注册护士和医生对这些因素中的每一个按1至10分的量表进行评分(10分为最重要),并计算每个因素的平均得分。然后将这些因素按重要性顺序排列(1分为最重要)。结果显示,腹膜炎总体上被列为决定治疗方式选择的最重要因素。一般来说,生活方式方面的考虑因素比特定治疗的医学后果排名更高。三组在某些方面存在一致性,但患者、注册护士和医生之间也存在差异。这就引发了关于患者咨询充分性的重要问题。

相似文献

1
ESRD treatment modality selection: which factors are important in the decision?终末期肾病治疗方式的选择:决策中哪些因素至关重要?
Adv Perit Dial. 1991;7:54-6.
2
[Comparison of quality of life in continuous ambulatory peritoneal dialysis and hemodialysis patients].
Zhonghua Nei Ke Za Zhi. 1993 Nov;32(11):754-6.
3
[Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].[持续性非卧床腹膜透析(CAPD)在慢性肾功能不全治疗方案中的作用。CAPD转为移植或血液透析所带来的问题]
Nephrologie. 1995;16(1):129-35.
4
Cost analysis of dialysis treatments for end-stage renal disease (ESRD).终末期肾病(ESRD)透析治疗的成本分析。
Clin Invest Med. 1995 Dec;18(6):455-64.
5
[Peritoneal dialysis in the aged].[老年人的腹膜透析]
Med Pregl. 1999 Sep-Oct;52(9-10):369-74.
6
[Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].[持续性非卧床腹膜透析或维持性血液透析的慢性肾衰竭患者多发性神经病变严重程度的评估]
Przegl Lek. 2007;64(6):423-30.
7
Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.腹膜透析是患有遗传性凝血障碍的终末期肾病患者的首选治疗方法。
Adv Perit Dial. 2000;16:170-3.
8
Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.持续性非卧床腹膜透析患者生存的预测因素:德黑兰两大中心的10年经验
Iran J Kidney Dis. 2010 Jan;4(1):44-9.
9
Content of a decision analysis for treatment choice in end-stage renal disease: who should be consulted?终末期肾病治疗选择的决策分析内容:应咨询谁?
Med Decis Making. 1994 Jan-Mar;14(1):91-7. doi: 10.1177/0272989X9401400111.
10
Choice of treatment improves quality of life. A study on patients undergoing dialysis.治疗方法的选择可改善生活质量。一项针对透析患者的研究。
Arch Intern Med. 1997 Jun 23;157(12):1352-6.

引用本文的文献

1
Choosing dialysis modality: decision making in a chronic illness context.选择透析方式:慢性病背景下的决策制定
Health Expect. 2014 Oct;17(5):710-23. doi: 10.1111/j.1369-7625.2012.00798.x. Epub 2012 Jul 2.
2
Who's for continuous ambulatory peritoneal dialysis?谁适合持续性非卧床腹膜透析?
BMJ. 1993 Jun 12;306(6892):1559-60. doi: 10.1136/bmj.306.6892.1559.
3
Differences in the treatment of male and female patients with end-stage renal disease.终末期肾病男性和女性患者治疗上的差异。
CMAJ. 1994 Nov 1;151(9):1283-8.